Author: Info

Rare Access: Science and the Future of Cannabinoids

Welcome to Rare Access: Demetrix, Future of Cannabinoids and the Role of Science, an ongoing special feature where we talk to leaders across the Demetrix team about advances in the regulation, science, and production of cannabinoids using fermentation. Have questions for our team? Submit them here! This week, we’re talking to Cindy Bryant, the Chief […]

Synthetic Cannabinoids: 3 Things to Know

  There’s a lot of discussion—and misinformation—out there about synthetic cannabinoids, so we wanted to take a quick look at this misunderstood class of molecules to separate fact from fiction. Here are three things that people need to know about synthetic cannabinoids. 3 Fast Facts on Synthetic Cannabinoids   #1. Cannabinoids produced using fermentation are […]

CBG Samples Now Available

Demetrix is Now Offering CBG Samples This week, we were excited to announce that Demetrix has begun to offer samples of our first product, the rare cannabinoid Cannabigerol, or CBG. You can read the full press release here. This news follows our successful 15,000 liter demo scale production milestone last month, and is an important […]

Demetrix Begins CBG sampling for Health & Wellness

Biotechnology company using fermentation to create rare cannabinoids begins delivering samples up to tens of grams, allowing skincare and consumer products companies to begin formulation work  BERKELEY, Calif – November 10, 2020 – Demetrix Inc., a biotechnology company that makes safe, legal and effective cannabinoids, today announced that it has launched a sampling program for […]

Why Fermentation?

Benefits of Fermentation, Our Approach, and the Demetrix Platform Demand for natural ingredients has never been higher. From consumer products to pharmaceuticals, companies that are hoping to build brands with natural products require a stable supply of high-quality, high-purity ingredients.  However, too often agriculture alone cannot meet this rapidly growing demand. Cannabinoids is just one […]

Demetrix Begins Demo Scale Production of Rare Cannabinoids

Biotechnology company focused on using fermentation to produce cannabinoids for safe, legal, and effective consumer products and pharmaceuticals scales to 15,000-liter production runs of CBG BERKELEY, Calif – September 3, 2020 – Demetrix Inc., a biotechnology company that makes safe and effective cannabinoids, today announced that it has commenced 15,000-liter demo-scale fermentation production of the […]